Join our community of smart investors

Croda trading weakly despite dividend, sales growth

Pharmaceutical, beauty divisions lead the way while deal with agricultural trading giant Cargill will focus the business in the coming months
March 1, 2022
  • Dividend up 9 per cent on sales, earnings  growth
  • Cargill deal set to close by the end of the Northern summer

Vaccines and consumer spending drove Croda International’s (CRDA) sales and profits higher in 2021, allowing management at the Yorkshire-based company to up its dividend by 10 per cent. 

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in